Records containing: NMO Spectrum Disorder
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-02-03Clinical Study on the Safety, Efficacy, and Pharmacokinetics of CD19-targeted CAR-T Cell Injection for the Treatment of Autoimmune Diseases Mediated by Autoantibodies.
-
CLINICAL_TRIALS study record update · 2026-01-29A Single-center, Prospective, Single-arm Clinical Study: Evaluation of the Efficacy and Safety of Transcranial Temporal Interference Stimulation (tTIS) for Neuropathic Pain in Neuromyelitis Optica Spectrum Disorder (NMOSD)
-
CLINICAL_TRIALS study record update · 2026-01-21Tongji NADs Cohort: A Real-world Observation of Neurological Autoimmune Disorders
-
CLINICAL_TRIALS study record update · 2025-12-12Clinical Impact Through AI-assisted MS Care - A Retrospective Multi-center Observational Study
-
CLINICAL_TRIALS study record update · 2025-09-08A Registry Study on Monoclonal Antibody-Based Therapies for Aquaporin-4 Antibody-Positive Neuromyelitis Optica Spectrum Disorders
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-08-17A Phase Ib Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of B001 in Subjects With Aquaporin-4 Antibody (AQP4-IgG) Positive Neuromyelitis Optic Spectrum Disorder (NMOSD)
-
CLINICAL_TRIALS study record update · 2025-07-16A Phase IIb Study of the Safety and Efficacy of Nabiximols in Subjects With Spasticity Due to Neuromyelitis Optica Spectrum Disorders: A Double-blind, Randomized, Placebo-Controlled, Crossover Study
-
CLINICAL_TRIALS study record update · 2025-06-15Safety and Efficacy of BAFF-R CART for Refractory Neuroimmune Diseases
-
CLINICAL_TRIALS study record update · 2025-05-20Assessment of Changes in Normal and Pathological Immune Factors in Patients Undergoing Plasma Exchange
-
CLINICAL_TRIALS study record update · 2025-03-30A Multi-center, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Daratumumab in Patients With Anti-Aquaporin 4 Antibody Positive Neuromyelitis Optica Spectrum Disorders (NMOSD)
-
CLINICAL_TRIALS study record update · 2025-01-07Acceptance and Commitment Therapy with Neuromyelitis Optica Spectrum Disorder Patient and Caregiver Pilot Study
-
CLINICAL_TRIALS study record update · 2024-12-24Prospective Cohort Study of CLinical and Imaging Patterns of NeUroinflammation DisEases (CLUE)
-
CLINICAL_TRIALS study record update · 2024-10-16Efficacy and Safety of Belimumab in Neuromyelitis Optica Spectrum Disorders (BEAT NMO)
-
CLINICAL_TRIALS study record update · 2024-10-16Efficacy and Safety of Baricitinib in Neuromyelitis Optica Spectrum Disorders
-
CLINICAL_TRIALS study record update · 2024-07-11FcRn Antagonists (Efgartigimod) for Acute Neuromyelitis Optica Spectrum Disorders (NMOSD) Attack: a Phase 2, Randomized Controlled Trial.
-
CLINICAL_TRIALS study record update · 2024-06-05National, Multicentric Registry Study on Neuroimmunological Diseases in China
-
CLINICAL_TRIALS study record update · 2024-04-10Pediatric Neuromyelitis Optica Spectrum Disorder (NMOSD) 1 Year Observational Study
-
CLINICAL_TRIALS study record update · 2024-02-05Cohort Study Evaluating the Epidemiological Characteristics of Coronavirus Infection (SARS-CoV-2) in Patients With MS or NMO
-
CLINICAL_TRIALS study record update · 2023-07-21China National Registry of Neuro-Inflammatory Diseases: a Prospective Cohort Study
-
CLINICAL_TRIALS study record update · 2023-06-09Monitoring of Azathioprine Metabolite Concentrations and Cytokine Levels in Neuromyelitis Optica Spectrum Disorder
-
CLINICAL_TRIALS study record update · 2023-02-24A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of LP-168 Following Single and Multiple Oral Administration to Healthy Volunteers
-
CLINICAL_TRIALS study record update · 2022-06-10Comparison of the Specificity, Sensitivity, and Clinical Correlation of Cell-based Assay (CBA) and CBA-TSA (Tyramide Signal Amplification) in Detecting AQP4, MOG, and NMDAR-IgG in Central Nervous System Diseases; a National Multicenter Study
-
CLINICAL_TRIALS study record update · 2022-01-25Safety, Tolerability, Pharmacodynamics and Efficacy of HBM9161 Weekly Subcutaneous Administration in Patients With Neuromyelitis Optica Spectrum Disorders (NMOSD) in China
-
CLINICAL_TRIALS study record update · 2021-03-30Computer Aided Imaging Evaluation of Central Nervous System Autoimmune Diseases
-
CLINICAL_TRIALS study record update · 2019-11-20Autologous Hematopoietic Stem Cell Transplant for Neuromyelitis Optica Spectrum Disorder (NMOSD)